Skip to main content

Table 4 Medication taken by patients with non-coronary chest pain (NCCP) and population controls after 6 years follow-up according to the postal survey distributed in 2005

From: Non-coronary chest pain does not affect long-term mortality: a prospective, observational study using a matched population control

  NCCP (n = 279) (%) Controls (n = 530) (%) p-value
ACE inhibitors 8.6 5.7 0.111
AII inhibitors 6.8 4.3 0.132
β-Blockers 27 16 <0.001
Ca2+-Blockers 8.6 6.6 0.299
Furosemide 6.5 6.0 0.816
Thiazides 15 8.5 0.004
Aspirin 18 11 0.013
Long-acting nitrates 4.7 1.1 0.002
Statins 13 9.2 0.078
Agents for acid-related disordersa 13 2.8 <0.001
Analgesics and NSAID 7.9 5.5 0.179
Anti-diabetic medication 4.7 4.2 0.735
COPD agents 7.5 3.6 0.014
Anti-depressants 7.9 6.0 0.317
Hypnotics and sedatives 10 8.1 0.358
  1. ACE angiotensin-converting enzyme, A II angiotensin II, NSAID non-steroidal anti-inflammatory drugs, COPD chronic obstructive pulmonary disease
  2. aAntacids, H2-receptor antagonists and proton pump inhibitors